Search Results - "Falup‐Pecurariu, C."

King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation by Chaudhuri, K. Ray, Rizos, A., Trenkwalder, C., Rascol, O., Pal, S., Martino, D., Carroll, C., Paviour, D., Falup-Pecurariu, C., Kessel, B., Silverdale, M., Todorova, A., Sauerbier, A., Odin, P., Antonini, A., Martinez-Martin, P.

“…Pain is a key unmet need and a major aspect of non‐motor symptoms of Parkinson's disease (PD). No specific validated scales exist to identify and grade the…”
Get full text

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire by Martinez‐Martin, P., Rizos, A. M., Wetmore, J., Antonini, A., Odin, P., Pal, S., Sophia, R., Carroll, C., Martino, D., Falup‐Pecurariu, C., Kessel, B., Andrews, T., Paviour, D., Trenkwalder, C., Chaudhuri, K. R.

“…Background and purpose Pain is highly prevalent in Parkinson's disease (PD), impacting patients’ ability, mood and quality of life. Detecting the presence of…”
Get full text

A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists by Rizos, A., Sauerbier, A., Antonini, A., Weintraub, D., Martinez-Martin, P., Kessel, B., Henriksen, T., Falup-Pecurariu, C., Silverdale, M., Durner, G., Røkenes Karlsen, K., Grilo, M., Odin, P., Chaudhuri, K. Ray

“…Background and purpose Impulse control disorders (ICDs) in Parkinson's disease (PD) are associated primarily with dopamine agonist (DA) use. Comparative…”
Get full text

The Parkinson's Disease Composite Scale: results of the first validation study by Stocchi, F., Radicati, F. G., Chaudhuri, K. R., Johansson, A., Padmakumar, C., Falup‐Pecurariu, C., Martinez‐Martin, P.

“…Background and purpose The aim was to validate the Parkinson's Disease Composite Scale (PDCS). Methods The study included 194 Parkinson's disease (PD) patients…”
Get full text

International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease by MARTINEZ-MARTIN, P, RODRIGUEZ-BLAZQUEZ, C, MIR, P, NAIDU, Y, NICOLETTI, A, SETHI, K, TSUBOI, Y, VAN HILTEN, J. J, VISSER, M, ZAPPIA, M, CHAUDHURI, K. R, ABE, K, BHATTACHARYYA, K. B, BLOEM, B. R, CAROD-ARTAL, F. J, PRAKASH, R, ESSELINK, R. A. J, FALUP-PECURARIU, C, GALLARDO, M

“…Nonmotor symptoms (NMS) have a great impact on patients with Parkinson disease (PD). The Non-Motor Symptoms Scale (NMSS) is an instrument specifically designed…”
Get full text

Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes by Valadas, A., Contarino, M-F., Albanese, A., Bhatia, K. P., Falup-Pecurariu, C., Forsgren, L., Friedman, A., Giladi, N., Hutchinson, M., Kostic, V. S., Krauss, J. K., Lokkegaard, A., Marti, M. J., Milanov, I., Pirtosek, Z., Relja, M., Skorvanek, M., Stamelou, M., Stepens, A., Tamás, G., Taravari, A., Tzoulis, C., Vandenberghe, W., Vidailhet, M., Ferreira, J. J., Tijssen, M. A.

“…© 2016 EAN Background and purpose: Dystonia is difficult to recognize due to its large phenomenological complexity. Thus, the use of experts in dystonia is…”
Get full text

The European association of young neurologists and trainees: advocating young neurologists in Europe by Struhal, W., Falup-Pecurariu, C., Sztriha, L., Sellner, J.

Get full text

Successful workshop on evidence-based neurology organized by the EAYNT and the Cochrane Neurological Network by Sztriha, L., Struhal, W., Falup-Pecurariu, C., Sellner, J.

Get full text

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease by Tall, P., Qamar, M. A., Batzu, L., Leta, V., Falup-Pecurariu, C., Ray Chaudhuri, K.

“…Continuous drug delivery (CDD) has emerged as a feasible and pragmatic therapeutic option for dopamine replacement therapy in advanced Parkinson’s disease…”
Get full text

MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study by Biundo, Roberta, Weis, L., Bostantjopoulou, S., Stefanova, E., Falup-Pecurariu, C., Kramberger, M. G., Geurtsen, G. J., Antonini, A., Weintraub, D., Aarsland, D.

“…The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are the most commonly used scales to test cognitive impairment in Lewy…”
Get full text

Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies by Moes, H. R., Dafsari, H. S., Jost, W. H., Kovacs, N., Pirtošek, Z., Henriksen, T., Falup-Pecurariu, C., Minár, M., Buskens, E., van Laar, T.

“…Several screening tools are available to assist general neurologists in the timely identification of patients with advanced Parkinson’s disease (PD) who may be…”
Get full text

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease by Jenner, P., Falup-Pecurariu, C., Leta, V., Verin, M., Auffret, M., Bhidayasiri, Roongroj, Weiss, D., Borovečki, F., Jost, W. H.

“…Dopaminergic therapies dominate the treatment of the motor and non-motor symptoms of Parkinson’s disease (PD) but there have been no major advances in therapy…”
Get full text

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey by Rizos, A., Sauerbier, A., Falup-Pecurariu, C., Odin, P., Antonini, A., Martinez-Martin, P., Kessel, B., Henriksen, T., Silverdale, M., Durner, G., Ray Chaudhuri, K.

“…In older patients with Parkinson’s disease (PD), the use of dopamine agonists (DA) has been limited due to uncertainties related to their tolerability in spite…”
Get full text

Sleep disturbances in systemic lupus erythematosus by Falup-Pecurariu, C, Duca, L, Moarcas, M

Get full text

High prevalence of restless legs syndrome in systemic lupus erythematosus by Falup-Pecurariu, C, Duca, L, Moarcas, M

“…Introduction Background : data regarding the sleep dysturbancies in systemic lupus erytematosous (SLE) are scarce. Objective : the aim of this study is to…”
Get full text

Self-reported autonomic symptoms in Parkinson's disease: properties of the SCOPA-AUT scale by Bostantjopoulou, S, Katsarou, Z, Danglis, I, Karakasis, H, Milioni, D, Falup-Pecurariu, C

“…Autonomic symptoms in Parkinson's disease (PD) are very common and contribute to the severity of patient's disability. We evaluated the occurrence of autonomic…”
Get full text

Prevalence of restless legs syndrome in chronic liver diseases€“ case-control study by Falup-Pecurariu, C, Coman, F, Moraru, G, Alexandru, R

“…Introduction Background : restless legs syndrome (RLS) is affecting the quality of sleep and is encountered in many diseases. There are few data on the…”
Get full text

Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria by Martinez-Martin, P, Falup-Pecurariu, C, Rodriguez-Blazquez, C, Serrano-Dueñas, M, Carod Artal, F.J, Rojo Abuin, J.M, Aarsland, D

“…Abstract Background Diagnostic criteria and procedures for dementia in Parkinson’s disease (PDD) have been proposed by a Movement Disorders Society Task Force…”
Get full text

Postencephalitic parkinsonism —/INS; case report by Falup-Pecurariu, C, Moarcas, M, Bustan, M, Chiperi, R, Alexandru, R

Get full text

Non-random temporal distribution of sleep onset REM periods in the MSLT in narcolepsy by Sansa, G, Falup-Pecurariu, C, Salamero, M, Iranzo, A, Santamaria, J

“…Introduction The diagnosis of narcolepsy is supported by the presence of two or more sleep onset REM periods (SOREMPs) in the multiple latency sleep test…”
Get full text